Cambridge Investment Research Advisors
NTR icon

Cambridge Investment Research Advisors’s Nutrien NTR Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NTR Stock Details NTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$777K Sell
12,342
-668
-5% -$46.7K ﹤0.01% 2353
2026
Q1 		$980K Buy
13,010
+24
+0.2% +$1.71K ﹤0.01% 2189
2025
Q4 		$802K Buy
12,986
+1,938
+18% +$114K ﹤0.01% 2290
2025
Q3 		$649K Sell
11,048
-4,497
-29% -$262K ﹤0.01% 2434
2025
Q2 		$905K Sell
15,545
-2,637
-15% -$149K ﹤0.01% 2032
2025
Q1 		$903K Sell
18,182
-778
-4% -$39.8K ﹤0.01% 1949
2024
Q4 		$848K Buy
18,960
+4,935
+35% +$234K ﹤0.01% 1999
2024
Q3 		$674K Sell
14,025
-1,328
-9% -$64K ﹤0.01% 2172
2024
Q2 		$782K Sell
15,353
-586
-4% -$32.1K ﹤0.01% 1946
2024
Q1 		$866K Sell
15,939
-246
-2% -$12.8K ﹤0.01% 1824
2023
Q4 		$912K Sell
16,185
-2,219
-12% -$125K ﹤0.01% 1708
2023
Q3 		$1.14M Sell
18,404
-4,620
-20% -$292K 0.01% 1481
2023
Q2 		$1.36M Sell
23,024
-2,005
-8% -$128K 0.01% 1404
2023
Q1 		$1.85M Sell
25,029
-5,253
-17% -$405K 0.01% 1173
2022
Q4 		$2.21M Buy
30,282
+2,055
+7% +$162K 0.01% 1025
2022
Q3 		$2.36M Sell
28,227
-9,655
-25% -$831K 0.01% 946
2022
Q2 		$3.01M Sell
37,882
-5,787
-13% -$562K 0.02% 846
2022
Q1 		$4.53M Buy
43,669
+23,279
+114% +$1.93M 0.02% 677
2021
Q4 		$1.53M Buy
20,390
+2,274
+13% +$159K 0.01% 1306
2021
Q3 		$1.18M Buy
18,116
+783
+5% +$47.9K 0.01% 1410
2021
Q2 		$1.05M Buy
17,333
+80
+0.5% +$4.73K 0.01% 1497
2021
Q1 		$930K Buy
17,253
+1,633
+10% +$88.8K 0.01% 1474
2020
Q4 		$751K Sell
15,620
-4,994
-24% -$221K ﹤0.01% 1489
2020
Q3 		$807K Buy
20,614
+3,785
+22% +$138K 0.01% 1309
2020
Q2 		$540K Buy
16,829
+95
+0.6% +$3.31K ﹤0.01% 1505
2020
Q1 		$567K Sell
16,734
-3,245
-16% -$130K 0.01% 1292
2019
Q4 		$957K Sell
19,979
-117
-0.6% -$5.65K 0.01% 1173
2019
Q3 		$1M Buy
20,096
+5,422
+37% +$277K 0.01% 1066
2019
Q2 		$784K Sell
14,674
-466
-3% -$24.3K 0.01% 1159
2019
Q1 		$799K Sell
15,140
-4,600
-23% -$240K 0.01% 1167
2018
Q4 		$928K Buy
19,740
+1,082
+6% +$56.4K 0.01% 967
2018
Q3 		$1.08M Buy
18,658
+522
+3% +$28.9K 0.01% 984
2018
Q2 		$986K Sell
18,136
-4,366
-19% -$217K 0.01% 989
2018
Q1 		$1.06M Buy
+22,502
New +$1.13M 0.01% 904

Other funds holding NTR

TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DKAM
Drummond Knight Asset Management Crows Nest, NSW, Australia $545M AUM 73.62% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
SII
Silchester International Investors London, United Kingdom $62M AUM 14.06% 1-Year Est. Return
TA
Townsend & Associates Westminster, Colorado $1.17B AUM 20.72% 1-Year Est. Return
LM
Lincluden Management Mississauga, Ontario, Canada $1.02B AUM 30.07% 1-Year Est. Return
CCMIC
Cardinal Capital Management Inc (Canada) Winnipeg, Manitoba, Canada $4.13B AUM 31.23% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Cambridge Investment Research Advisors's NTR Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Nutrien (NTR) stake by 5.1% in Q2 2026, selling an estimated $46.7K and leaving 12,342 shares worth $777K. The position accounts for ﹤0.01% of the portfolio, ranked #2353.

Cambridge Investment Research Advisors first reported a position in NTR in Q1 2018 and has held it in 34 quarters since. The position peaked at $4.53M in Q1 2022. 177 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Cambridge Investment Research Advisors held 12,342 shares of Nutrien worth $777K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 668 Nutrien shares in Q2 2026, an estimated $46.7K.
  • Nutrien made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2353 holding.
  • Cambridge Investment Research Advisors first reported a position in Nutrien in Q1 2018 and has held it in 34 quarters since.
  • Cambridge Investment Research Advisors's Nutrien position peaked at $4.53M in Q1 2022.
  • 177 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.